Bionano Genomics, Inc. (NASDAQ:BNGO) Sees Large Decrease in Short Interest

Bionano Genomics, Inc. (NASDAQ:BNGO - Get Free Report) was the target of a large drop in short interest in January. As of January 15th, there was short interest totalling 341,500 shares, a drop of 98.1% from the December 31st total of 17,650,000 shares. Approximately 14.7% of the company's stock are sold short. Based on an average daily volume of 143,900 shares, the days-to-cover ratio is currently 2.4 days.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC increased its stake in Bionano Genomics by 47.3% in the third quarter. Geode Capital Management LLC now owns 882,854 shares of the company's stock valued at $401,000 after purchasing an additional 283,639 shares during the period. GSA Capital Partners LLP acquired a new position in Bionano Genomics in the third quarter valued at $46,000. Finally, Carret Asset Management LLC increased its stake in Bionano Genomics by 89.0% in the third quarter. Carret Asset Management LLC now owns 85,055 shares of the company's stock valued at $39,000 after purchasing an additional 40,055 shares during the period. 11.35% of the stock is currently owned by institutional investors and hedge funds.

Bionano Genomics Stock Up 2.1 %

NASDAQ:BNGO traded up $0.11 during midday trading on Monday, hitting $5.30. 233,019 shares of the company were exchanged, compared to its average volume of 352,736. The company has a fifty day simple moving average of $12.81 and a 200 day simple moving average of $20.84. Bionano Genomics has a fifty-two week low of $4.75 and a fifty-two week high of $81.00. The company has a current ratio of 1.43, a quick ratio of 0.99 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $10.35 million, a PE ratio of -0.04 and a beta of 2.22.

Analysts Set New Price Targets

Separately, LADENBURG THALM/SH SH lowered shares of Bionano Genomics from a "buy" rating to a "neutral" rating in a report on Friday, November 15th.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.